The Global Prenatal Testing and Newborn Screening Market report provides full coverage of the companies’ data, including details about their production and manufacturing capacity, product portfolio, business overview, revenue, gross profit margins, sales network and distribution channel, financial standing, and market position. The report also studies business strategies and strategic alliances undertaken by companies to footing in the gain a robust market. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. Growing prevalence of chromosome syndrome in babies is one of the significant factors influencing the market growth.The comprehensive analysis of the competitive landscape offers the readers a deeper understanding about the competitors.

Key participants include Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/346

 The study offers comprehensive coverage of the qualitative and quantitative analysis of the Prenatal Testing and Newborn Screening market along with crucial statistical data about the Prenatal Testing and Newborn Screening market. The research study provides historical data from 2017 to 2018 and offers accurate forecast estimation until 2027. The report also profiles established and emerging players of the market, covering the business overview, product portfolio, strategic alliances, and business expansion strategies.

Prenatal testing enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.\

In April 2019, Progenity Inc. made an announcement about the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases.

The market intelligence report gives business evangelists an authority to review the major trends, opportunities, and challenges expected to shape the future of the industry during the estimated period. Importantly, the study not only helps spot the major vendors but also their winning strategies.Growing prevalence of chromosome syndrome in babies is one of the significant factors influencing the market growth.The report offers a comprehensive breakdown of the regional analysis of the market and subsequent country-wise analysis. The regional analysis of the market comprises of production volume information, consumption volume and patterns, revenue, and growth rate for the forecast period of 2020-2027

Ultrasonography is projected to observe a significant growth rate in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.

The hospital held a substantial market share in 2019 due to the growing introduction of non-invasive prenatal testing, coupled with rapid technological developments in newborn screening, the presence of skilled professionals, and better reimbursement scenario.

The increasing popularity among pregnant women as an alternative to amniocentesis and awareness of genetic problems in the fetus and newborn babies drives prenatal testing and newborn screening market.

Request customization of the report: https://www.emergenresearch.com/request-for-customization/346

Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

• Prenatal Testing
• Newborn Screening

Test Type Outlook (Revenue, USD Billion; 2017-2027)

• Non-Invasive
• Invasive

Technology Outlook (Revenue, USD Billion; 2017-2027)

• Mass Spectrometry
• Electrophoresis
• Enzyme Immunoassays
• DNA Assays

Instrument Outlook (Revenue, USD Billion; 2017-2027)

• Ultrasonography
• Reagent and Assay Kits
• Tandem Quadrupole Detector
• Incubator Shaker
• Hearing Screen Instruments

End Users Outlook (Revenue, USD Billion; 2017-2027)

• Hospitals
• Maternity Specialty Clinics
• Diagnostic Centers

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America
  1. U.S.
  2. Canada
  3. Mexico
• Europe
  1. Germany
  2. UK
  3. France
  4. BENELUX
  5. Rest of Europe
• Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• MEA
  1. Saudi Arabia
  2. UAE
  3. Rest of MEA

Read More: https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market

Related Reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research    and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs